美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

康乃德生物醫藥

1.15

-0.5750-33.33%

成交量：798.90萬

成交額：934.57萬

市值：7,240.84萬

市盈率：-0.96

高：1.30

開：1.28

低：1.10

收：1.73

52周最高：3.82

52周最低：1.10

股本：6,296.39萬

流通股本：2,106.61萬

量比：17.64

換手率：37.92%

股息：- -

股息率：- -

每股收益(TTM):-1.1933

每股收益(LYR):-1.0000

淨資產收益率：-140.51%

總資產收益率：-69.75%

市淨率：2.70

市盈率(LYR):-1.15

資料載入中...

總覽公司新聞資訊公告

Connect Biopharma股價下跌，因其哮喘藥物在早期研究中未達到主要目標

康乃德生物醫藥：Rademikibart在哮喘患者中展現良好耐受性與低不良事件發生率

康乃德生物醫藥：Rademikibart在第7天展現統計學顯著肺功能改善

康乃德生物醫藥公布Rademikibart全球II期研究積極初步頂線數據：作為成人與青少年哮喘合併2型炎症患者急性加重期的附加治療

奧本海默首予康乃德生物醫藥「跑贏大盤」評級，目標價8美元

Piper Sandler首予康乃德生物醫藥「增持」評級，目標價7美元

康乃德生物醫藥宣佈完成評估雷迪米基巴治療哮喘急性發作的II期海風研究患者入組

康乃德生物醫藥控股有限公司 - 計劃轉售至多610萬股普通股 - 美國證券交易委員會文件披露

康乃德生物醫藥：兩項Seabreeze Stat研究頂線結果預計年中公布，目前進展順利

康乃德生物醫藥：數據監測委員會報告Seabreeze Stat研究無安全隱患或治療相關嚴重不良事件

康乃德生物醫藥：預設定中期分析後，Seabreeze二期研究將按計劃繼續推進患者入組

康乃德生物醫藥公布靜脈注射雷德米基巴治療哮喘或慢阻肺患者一期研究積極頂線數據

BUZZ-濕疹藥物在中國研究中顯示出持久療效，Connect 生物製藥公司業績上升

康乃德生物醫藥宣佈完成2020萬美元私募融資資金儲備將支撐運營至2027年下半年

康乃德生物醫藥Rademikibart在長達52周的特應性皮炎3期研究中展現快速且持久的療效

康乃德生物醫藥公布靜脈注射Rademikibart針對哮喘或慢阻肺患者一期研究的積極頂線數據

康乃德生物醫藥Rademikibart 300毫克靜脈推注在哮喘與慢阻肺治療中實現FEV1快速改善≥200毫升

康乃德生物醫藥Rademikibart耐受性良好，未出現嚴重或重度不良事件

康乃德生物醫藥Seabreeze Stat二期研究持續招募受試者，頂線數據預計2026年中公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/CNTB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNTB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"康乃德生物醫藥","latestPrice":1.15,"timestamp":1789487114657,"preClose":1.725,"halted":0,"volume":7988969,"delay":0,"changeRate":-0.3333333333333334,"floatShares":21066100,"shares":62963853,"eps":-1.193347,"marketStatus":"交易中","change":-0.575,"latestTime":"09-15 11:45:19 EDT","open":1.28,"high":1.3,"low":1.1,"amount":9345726.817404099,"amplitude":0.115942,"askPrice":1.16,"askSize":5224,"bidPrice":1.15,"bidSize":879,"shortable":0,"etf":0,"ttmEps":-1.193347,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":1.725,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.725,"latestTime":"09:29 EDT","volume":1772839,"amount":2056314.8923966,"timestamp":1789478999999,"change":-0.445,"changeRate":-0.257971,"amplitude":0.559478},"postHourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.725,"latestTime":"19:59 EDT","volume":33637,"amount":58521.9255,"timestamp":1789430350175,"change":0.015,"changeRate":0.008696,"amplitude":0.043478},"volumeRatio":17.638973,"impliedVol":2.7889,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","floatShares":21066100,"roa":"-69.75%","roe":"-140.51%","lyrEps":-1,"volumeRatio":17.638973,"shares":62963853,"dividePrice":0,"high":1.3,"amplitude":0.115942,"preClose":1.725,"low":1.1,"week52Low":1.1,"pbRate":"2.70","psRate":"24.52","week52High":3.82,"institutionHeld":0,"latestPrice":1.15,"committee":-0.711945,"eps":-1.193347,"divideRate":0,"volume":7988969,"delay":0,"ttmEps":-1.193347,"open":1.28,"prevYearClose":2.82,"prevWeekClose":2.04,"prevMonthClose":2.2,"prevQuarterClose":2.38,"fiveDayClose":1.91,"twentyDayClose":2.49,"sixtyDayClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNTB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"CNTB","fiscalQuarterEnding":"2026/06","expectedEps":-0.32,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2026-05-12","symbol":"CNTB","fiscalQuarterEnding":"2026/03","expectedEps":-0.29,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2026-03-31","symbol":"CNTB","fiscalQuarterEnding":"2025/12","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-11-12","symbol":"CNTB","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2025-08-13","symbol":"CNTB","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNTB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNTB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1783828800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNTB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNTB","date":"2026-09-14","current":-1.445514,"percent":0.445082,"low":-7.684972,"twenty":-2.756774,"median":-1.233649,"eighty":-0.533541,"high":-0.159163,"avg":-1.668597,"sd":1.26966,"marketCap":128467590},"quantilePoints":[{"date":"2021-09-17","current":-4.801642,"twenty":-9.723079,"median":-7.710258,"eighty":-6.831074,"marketCap":1222705998},{"date":"2021-09-24","current":-4.489307,"twenty":-9.696523,"median":-7.662771,"eighty":-6.554186,"marketCap":1143171783},{"date":"2021-10-01","current":-4.843137,"twenty":-9.645339,"median":-7.632136,"eighty":-6.431352,"marketCap":1237022157},{"date":"2021-10-08","current":-3.807848,"twenty":-9.620408,"median":-7.603768,"eighty":-6.251971,"marketCap":972968563},{"date":"2021-10-15","current":-3.558007,"twenty":-9.616281,"median":-7.586295,"eighty":-5.019272,"marketCap":910401647},{"date":"2021-10-22","current":-3.355537,"twenty":-9.566602,"median":-7.52994,"eighty":-4.833909,"marketCap":865332259},{"date":"2021-10-29","current":-3.267452,"twenty":-9.502865,"median":-7.441275,"eighty":-4.780728,"marketCap":839881310},{"date":"2021-11-05","current":-3.253783,"twenty":-9.469894,"median":-7.327725,"eighty":-4.593046,"marketCap":837230169},{"date":"2021-11-12","current":-2.966436,"twenty":-9.453591,"median":-7.216094,"eighty":-4.483697,"marketCap":765649376},{"date":"2021-11-19","current":-1.053194,"twenty":-9.259982,"median":-7.152997,"eighty":-4.330678,"marketCap":271476787},{"date":"2021-11-26","current":-0.926282,"twenty":-9.13122,"median":-7.138841,"eighty":-4.174663,"marketCap":238602645},{"date":"2021-12-03","current":-0.915809,"twenty":-9.086801,"median":-7.12805,"eighty":-3.589981,"marketCap":236481732},{"date":"2021-12-10","current":-0.890151,"twenty":-8.969361,"median":-7.109723,"eighty":-3.473393,"marketCap":230118995},{"date":"2021-12-17","current":-0.932161,"twenty":-8.830139,"median":-7.102727,"eighty":-3.378137,"marketCap":240723557},{"date":"2021-12-23","current":-0.943664,"twenty":-8.746242,"median":-6.915567,"eighty":-3.258613,"marketCap":243904926},{"date":"2021-12-31","current":-1.05356,"twenty":-8.697693,"median":-6.840905,"eighty":-3.199128,"marketCap":273067471},{"date":"2022-01-07","current":-0.946776,"twenty":-8.615675,"median":-6.8278,"eighty":-2.990554,"marketCap":244435154},{"date":"2022-01-14","current":-1.051564,"twenty":-8.586449,"median":-6.62613,"eighty":-2.739352,"marketCap":272537243},{"date":"2022-01-21","current":-1.000269,"twenty":-8.511604,"median":-6.513569,"eighty":-2.490275,"marketCap":259811769},{"date":"2022-01-28","current":-0.878785,"twenty":-8.391559,"median":-6.439938,"eighty":-1.053194,"marketCap":227467854},{"date":"2022-02-04","current":-1.01194,"twenty":-8.317939,"median":-6.3296,"eighty":-1.046595,"marketCap":261932681},{"date":"2022-02-11","current":-0.914897,"twenty":-8.307941,"median":-6.197118,"eighty":-1.013637,"marketCap":237011960},{"date":"2022-02-18","current":-0.918769,"twenty":-8.284524,"median":-5.043435,"eighty":-1.005795,"marketCap":239132873},{"date":"2022-02-25","current":-0.764942,"twenty":-8.278042,"median":-5.000788,"eighty":-0.982029,"marketCap":199365765},{"date":"2022-03-04","current":-0.826184,"twenty":-8.235445,"median":-4.843137,"eighty":-0.964922,"marketCap":215272608},{"date":"2022-03-11","current":-0.634904,"twenty":-8.186332,"median":-4.812188,"eighty":-0.954055,"marketCap":164900939},{"date":"2022-03-18","current":-1.01402,"twenty":-8.156045,"median":-4.749358,"eighty":-0.948264,"marketCap":262462909},{"date":"2022-03-25","current":-0.633398,"twenty":-8.055669,"median":-4.610802,"eighty":-0.938787,"marketCap":163840482},{"date":"2022-04-01","current":-0.817881,"twenty":-8.017808,"median":-4.56151,"eighty":-0.931801,"marketCap":167982772},{"date":"2022-04-08","current":-0.769746,"twenty":-8.010106,"median":-4.482295,"eighty":-0.925482,"marketCap":158069035},{"date":"2022-04-14","current":-0.768664,"twenty":-7.979319,"median":-4.405731,"eighty":-0.918413,"marketCap":157518272},{"date":"2022-04-22","current":-0.739819,"twenty":-7.913151,"median":-4.287019,"eighty":-0.914458,"marketCap":148706061},{"date":"2022-04-29","current":-0.56539,"twenty":-7.875607,"median":-4.176153,"eighty":-0.900786,"marketCap":111804927},{"date":"2022-05-06","current":-0.17557,"twenty":-7.868211,"median":-3.670547,"eighty":-0.888287,"marketCap":34417191},{"date":"2022-05-13","current":-0.214562,"twenty":-7.860784,"median":-3.53283,"eighty":-0.874894,"marketCap":41307239},{"date":"2022-05-20","current":-0.256686,"twenty":-7.838167,"median":-3.475686,"eighty":-0.852444,"marketCap":50119450},{"date":"2022-05-27","current":-0.239989,"twenty":-7.802485,"median":-3.447182,"eighty":-0.827995,"marketCap":46814871},{"date":"2022-06-03","current":-0.222507,"twenty":-7.779984,"median":-3.383787,"eighty":-0.815856,"marketCap":43658998},{"date":"2022-06-10","current":-0.234674,"twenty":-7.766282,"median":-3.267452,"eighty":-0.803106,"marketCap":45713344},{"date":"2022-06-17","current":-0.214333,"twenty":-7.741192,"median":-3.248328,"eighty":-0.783474,"marketCap":41701960},{"date":"2022-06-24","current":-0.253451,"twenty":-7.707419,"median":-3.211747,"eighty":-0.770941,"marketCap":49514201},{"date":"2022-07-01","current":-0.255161,"twenty":-7.690632,"median":-3.158228,"eighty":-0.76458,"marketCap":49761772},{"date":"2022-07-08","current":-0.245152,"twenty":-7.66891,"median":-2.966436,"eighty":-0.74871,"marketCap":47863727},{"date":"2022-07-15","current":-0.258726,"twenty":-7.656633,"median":-2.926464,"eighty":-0.68542,"marketCap":50036851},{"date":"2022-07-22","current":-0.234638,"twenty":-7.653926,"median":-2.676357,"eighty":-0.656046,"marketCap":45415525},{"date":"2022-07-29","current":-0.231464,"twenty":-7.632136,"median":-1.85068,"eighty":-0.633398,"marketCap":44848863},{"date":"2022-08-05","current":-0.375753,"twenty":-7.629019,"median":-1.05356,"eighty":-0.56539,"marketCap":72620828},{"date":"2022-08-12","current":-0.397407,"twenty":-7.612804,"median":-1.051572,"eighty":-0.51804,"marketCap":77022090},{"date":"2022-08-19","current":-0.393211,"twenty":-7.594732,"median":-1.046595,"eighty":-0.451463,"marketCap":75371617},{"date":"2022-08-26","current":-0.428161,"twenty":-7.588517,"median":-1.025955,"eighty":-0.413444,"marketCap":81423352},{"date":"2022-09-02","current":-0.389232,"twenty":-7.586295,"median":-1.013637,"eighty":-0.408638,"marketCap":73721143},{"date":"2022-09-09","current":-0.408187,"twenty":-7.581909,"median":-1.011955,"eighty":-0.403502,"marketCap":77022090},{"date":"2022-09-16","current":-0.723373,"twenty":-7.579597,"median":-1.003032,"eighty":-0.405606,"marketCap":79222721},{"date":"2022-09-23","current":-0.60438,"twenty":-7.500328,"median":-0.983258,"eighty":-0.407767,"marketCap":64918619},{"date":"2022-09-30","current":-0.659467,"twenty":-7.470775,"median":-0.967989,"eighty":-0.408548,"marketCap":70970354},{"date":"2022-10-07","current":-0.552143,"twenty":-7.446684,"median":-0.964367,"eighty":-0.409978,"marketCap":59417041},{"date":"2022-10-14","current":-0.488722,"twenty":-7.362202,"median":-0.955013,"eighty":-0.410887,"marketCap":52033923},{"date":"2022-10-21","current":-0.475948,"twenty":-7.332162,"median":-0.951472,"eighty":-0.412961,"marketCap":50328434},{"date":"2022-10-28","current":-0.454861,"twenty":-7.326603,"median":-0.94522,"eighty":-0.415335,"marketCap":48017771},{"date":"2022-11-04","current":-0.373701,"twenty":-7.240513,"median":-0.939366,"eighty":-0.415335,"marketCap":39831423},{"date":"2022-11-11","current":-0.352484,"twenty":-7.216711,"median":-0.934342,"eighty":-0.408548,"marketCap":37971890},{"date":"2022-11-18","current":-0.377052,"twenty":-7.203001,"median":-0.930363,"eighty":-0.402747,"marketCap":40546629},{"date":"2022-11-25","current":-0.382688,"twenty":-7.173915,"median":-0.926282,"eighty":-0.397285,"marketCap":40860219},{"date":"2022-12-02","current":-0.361406,"twenty":-7.152256,"median":-0.920821,"eighty":-0.383534,"marketCap":39418805},{"date":"2022-12-09","current":-0.358359,"twenty":-7.143839,"median":-0.918109,"eighty":-0.380898,"marketCap":39440811},{"date":"2022-12-16","current":-0.350715,"twenty":-7.138568,"median":-0.915353,"eighty":-0.380898,"marketCap":38516546},{"date":"2022-12-23","current":-0.379125,"twenty":-7.1364,"median":-0.908751,"eighty":-0.378676,"marketCap":41542469},{"date":"2022-12-30","current":-0.430096,"twenty":-7.13263,"median":-0.90479,"eighty":-0.377809,"marketCap":47742693},{"date":"2023-01-06","current":-0.417597,"twenty":-7.126486,"median":-0.891571,"eighty":-0.378227,"marketCap":46763412},{"date":"2023-01-13","current":-0.476852,"twenty":-7.118423,"median":-0.887821,"eighty":-0.379443,"marketCap":54410605},{"date":"2023-01-20","current":-0.526363,"twenty":-7.111187,"median":-0.881989,"eighty":-0.380713,"marketCap":59417041},{"date":"2023-01-27","current":-0.623924,"twenty":-7.10826,"median":-0.873573,"eighty":-0.381022,"marketCap":70420197},{"date":"2023-02-03","current":-0.558865,"twenty":-7.106105,"median":-0.856826,"eighty":-0.38112,"marketCap":63273647},{"date":"2023-02-10","current":-0.54294,"twenty":-7.102727,"median":-0.842419,"eighty":-0.381865,"marketCap":61067514},{"date":"2023-02-17","current":-0.528021,"twenty":-6.926245,"median":-0.827693,"eighty":-0.382688,"marketCap":58866883},{"date":"2023-02-24","current":-0.569815,"twenty":-6.917703,"median":-0.817662,"eighty":-0.383186,"marketCap":62717988},{"date":"2023-03-03","current":-0.610413,"twenty":-6.881749,"median":-0.808922,"eighty":-0.383608,"marketCap":67669408},{"date":"2023-03-10","current":-0.527318,"twenty":-6.852745,"median":-0.803422,"eighty":-0.384285,"marketCap":58316725},{"date":"2023-03-17","current":-0.544298,"twenty":-6.836883,"median":-0.794928,"eighty":-0.388273,"marketCap":60517356},{"date":"2023-03-24","current":-0.473741,"twenty":-6.833445,"median":-0.778365,"eighty":-0.390596,"marketCap":52815147},{"date":"2023-03-31","current":-0.493552,"twenty":-6.828891,"median":-0.769746,"eighty":-0.391232,"marketCap":55010277},{"date":"2023-04-06","current":-0.52866,"twenty":-6.807965,"median":-0.768585,"eighty":-0.392449,"marketCap":58866883},{"date":"2023-04-14","current":-0.536009,"twenty":-6.73547,"median":-0.762362,"eighty":-0.395546,"marketCap":62196609},{"date":"2023-04-21","current":-0.498318,"twenty":-6.612165,"median":-0.74871,"eighty":-0.397285,"marketCap":57793309},{"date":"2023-04-28","current":-0.497275,"twenty":-6.553128,"median":-0.731818,"eighty":-0.399415,"marketCap":57242896},{"date":"2023-05-05","current":-0.544069,"twenty":-6.506081,"median":-0.709336,"eighty":-0.401809,"marketCap":62747021},{"date":"2023-05-11","current":-0.556594,"twenty":-6.47471,"median":-0.701012,"eighty":-0.40263,"marketCap":63847846},{"date":"2023-05-19","current":-0.588283,"twenty":-6.459526,"median":-0.687882,"eighty":-0.403154,"marketCap":66599908},{"date":"2023-05-26","current":-0.566751,"twenty":-6.431352,"median":-0.678549,"eighty":-0.404244,"marketCap":63847846},{"date":"2023-06-02","current":-0.543961,"twenty":-6.418474,"median":-0.672932,"eighty":-0.405096,"marketCap":61095784},{"date":"2023-06-08","current":-0.554893,"twenty":-6.355881,"median":-0.659873,"eighty":-0.40589,"marketCap":62196609},{"date":"2023-06-16","current":-0.497477,"twenty":-6.327473,"median":-0.655458,"eighty":-0.407348,"marketCap":55591659},{"date":"2023-06-23","current":-0.614773,"twenty":-6.306796,"median":-0.649124,"eighty":-0.408367,"marketCap":68251146},{"date":"2023-06-30","current":-0.555865,"twenty":-6.294625,"median":-0.644385,"eighty":-0.408548,"marketCap":61095784},{"date":"2023-07-06","current":-0.575855,"twenty":-6.270255,"median":-0.64183,"eighty":-0.408973,"marketCap":63297434},{"date":"2023-07-14","current":-0.558006,"twenty":-6.197118,"median":-0.634151,"eighty":-0.410313,"marketCap":62196609},{"date":"2023-07-21","current":-0.535216,"twenty":-5.186666,"median":-0.627919,"eighty":-0.411031,"marketCap":59444546},{"date":"2023-07-28","current":-0.495387,"twenty":-5.058382,"median":-0.626447,"eighty":-0.411478,"marketCap":55041247},{"date":"2023-08-04","current":-0.475069,"twenty":-5.028488,"median":-0.624235,"eighty":-0.413444,"marketCap":52839597},{"date":"2023-08-11","current":-0.463522,"twenty":-5.005447,"median":-0.623221,"eighty":-0.415808,"marketCap":51188359},{"date":"2023-08-18","current":-0.453142,"twenty":-4.996129,"median":-0.614773,"eighty":-0.416116,"marketCap":49537122},{"date":"2023-08-25","current":-0.412067,"twenty":-4.883081,"median":-0.606902,"eighty":-0.415808,"marketCap":45133822},{"date":"2023-09-01","current":-0.413906,"twenty":-4.843137,"median":-0.600278,"eighty":-0.412385,"marketCap":45453061},{"date":"2023-09-08","current":-0.394786,"twenty":-4.824681,"median":-0.597524,"eighty":-0.411389,"marketCap":42937676},{"date":"2023-09-15","current":-0.553612,"twenty":-4.814942,"median":-0.596714,"eighty":-0.410887,"marketCap":46234647},{"date":"2023-09-22","current":-0.431749,"twenty":-4.811303,"median":-0.589983,"eighty":-0.411389,"marketCap":35906656},{"date":"2023-09-29","current":-0.493437,"twenty":-4.803456,"median":-0.588992,"eighty":-0.411949,"marketCap":41072368},{"date":"2023-10-06","current":-0.621906,"twenty":-4.759815,"median":-0.589869,"eighty":-0.412067,"marketCap":51767265},{"date":"2023-10-13","current":-0.582179,"twenty":-4.685168,"median":-0.589926,"eighty":-0.412321,"marketCap":48462971},{"date":"2023-10-20","current":-0.782186,"twenty":-4.631088,"median":-0.595176,"eighty":-0.412783,"marketCap":64984439},{"date":"2023-10-27","current":-0.758864,"twenty":-4.617269,"median":-0.595506,"eighty":-0.412995,"marketCap":63034906},{"date":"2023-11-03","current":-0.92881,"twenty":-4.596535,"median":-0.597168,"eighty":-0.413536,"marketCap":77155254},{"date":"2023-11-10","current":-1.055984,"twenty":-4.578364,"median":-0.598624,"eighty":-0.414286,"marketCap":88114494},{"date":"2023-11-17","current":-1.305878,"twenty":-4.558808,"median":-0.604483,"eighty":-0.41587,"marketCap":109592402},{"date":"2023-11-24","current":-0.835288,"twenty":-4.548002,"median":-0.609664,"eighty":-0.416116,"marketCap":71042311},{"date":"2023-12-01","current":-0.74365,"twenty":-4.489307,"median":-0.614773,"eighty":-0.417326,"marketCap":63332292},{"date":"2023-12-08","current":-0.602179,"twenty":-4.475282,"median":-0.621384,"eighty":-0.417597,"marketCap":51216549},{"date":"2023-12-15","current":-0.49234,"twenty":-4.418471,"median":-0.610413,"eighty":-0.420523,"marketCap":42135249},{"date":"2023-12-22","current":-0.537452,"twenty":-4.392992,"median":-0.609656,"eighty":-0.421884,"marketCap":45742436},{"date":"2023-12-29","current":-0.708246,"twenty":-4.373067,"median":-0.609218,"eighty":-0.423709,"marketCap":60578714},{"date":"2024-01-05","current":-0.789997,"twenty":-4.345231,"median":-0.610101,"eighty":-0.424968,"marketCap":67187301},{"date":"2024-01-12","current":-0.739514,"twenty":-4.284263,"median":-0.614773,"eighty":-0.42546,"marketCap":62924763},{"date":"2024-01-19","current":-0.697741,"twenty":-4.273239,"median":-0.621906,"eighty":-0.426746,"marketCap":58926568},{"date":"2024-01-26","current":-0.841231,"twenty":-4.183606,"median":-0.623949,"eighty":-0.427141,"marketCap":71593026},{"date":"2024-02-02","current":-0.65717,"twenty":-4.168701,"median":-0.625511,"eighty":-0.428161,"marketCap":55622274},{"date":"2024-02-09","current":-0.719854,"twenty":-3.807848,"median":-0.627255,"eighty":-0.430096,"marketCap":61129430},{"date":"2024-02-16","current":-0.785847,"twenty":-3.670547,"median":-0.628587,"eighty":-0.430295,"marketCap":66636586},{"date":"2024-02-23","current":-0.703977,"twenty":-3.644463,"median":-0.629181,"eighty":-0.430329,"marketCap":59477283},{"date":"2024-03-01","current":-0.768787,"twenty":-3.573994,"median":-0.637061,"eighty":-0.431467,"marketCap":64984439},{"date":"2024-03-08","current":-0.782256,"twenty":-3.517724,"median":-0.642819,"eighty":-0.432231,"marketCap":66096885},{"date":"2024-03-15","current":-0.730103,"twenty":-3.500919,"median":-0.648502,"eighty":-0.435038,"marketCap":61680146},{"date":"2024-03-22","current":-0.808945,"twenty":-3.480396,"median":-0.652377,"eighty":-0.435836,"marketCap":68288733},{"date":"2024-03-28","current":-1.054383,"twenty":-3.473393,"median":-0.654869,"eighty":-0.436123,"marketCap":88665209},{"date":"2024-04-05","current":-1.179969,"twenty":-3.465214,"median":-0.658098,"eighty":-0.440275,"marketCap":99128806},{"date":"2024-04-12","current":-1.259189,"twenty":-3.444462,"median":-0.660278,"eighty":-0.443139,"marketCap":105737393},{"date":"2024-04-19","current":-1.407563,"twenty":-3.420656,"median":-0.672034,"eighty":-0.443489,"marketCap":83754210},{"date":"2024-04-26","current":-1.259398,"twenty":-3.378137,"median":-0.676202,"eighty":-0.44479,"marketCap":74937977},{"date":"2024-05-03","current":-1.435344,"twenty":-3.320017,"median":-0.681097,"eighty":-0.44561,"marketCap":85407253},{"date":"2024-05-10","current":-1.32422,"twenty":-3.279006,"median":-0.684378,"eighty":-0.446408,"marketCap":78795079},{"date":"2024-05-17","current":-1.592768,"twenty":-3.260823,"median":-0.693504,"eighty":-0.447635,"marketCap":94774500},{"date":"2024-05-24","current":-1.666851,"twenty":-3.254831,"median":-0.701012,"eighty":-0.448794,"marketCap":99182617},{"date":"2024-05-31","current":-1.449234,"twenty":-3.249419,"median":-0.704085,"eighty":-0.449278,"marketCap":86233775},{"date":"2024-06-07","current":-1.518686,"twenty":-3.238835,"median":-0.706334,"eighty":-0.4494,"marketCap":90366384},{"date":"2024-06-14","current":-1.555727,"twenty":-3.224366,"median":-0.708791,"eighty":-0.449677,"marketCap":92570442},{"date":"2024-06-21","current":-1.340148,"twenty":-3.190715,"median":-0.71884,"eighty":-0.450315,"marketCap":79742824},{"date":"2024-06-28","current":-1.185316,"twenty":-3.183833,"median":-0.721224,"eighty":-0.450774,"marketCap":70529861},{"date":"2024-07-05","current":-1.240878,"twenty":-3.170454,"median":-0.723582,"eighty":-0.451545,"marketCap":73835948},{"date":"2024-07-12","current":-1.176056,"twenty":-3.143988,"median":-0.729841,"eighty":-0.451982,"marketCap":69978846},{"date":"2024-07-15","current":-1.157535,"twenty":-3.129748,"median":-0.729947,"eighty":-0.452091,"marketCap":68876817},{"date":"2024-08-02","current":-1.092713,"twenty":-3.115508,"median":-0.730052,"eighty":-0.452201,"marketCap":65019715},{"date":"2024-08-09","current":-0.98159,"twenty":-3.014673,"median":-0.736133,"eighty":-0.452774,"marketCap":58407541},{"date":"2024-08-16","current":-1.092713,"twenty":-2.961387,"median":-0.739819,"eighty":-0.45309,"marketCap":65019715},{"date":"2024-08-23","current":-0.935288,"twenty":-2.949349,"median":-0.74874,"eighty":-0.453588,"marketCap":55652468},{"date":"2024-08-30","current":-1.185316,"twenty":-2.923043,"median":-0.750977,"eighty":-0.454471,"marketCap":70529861},{"date":"2024-09-06","current":-1.101881,"twenty":-2.824357,"median":-0.754751,"eighty":-0.455485,"marketCap":65565220},{"date":"2024-09-13","current":-3.101255,"twenty":-3.038791,"median":-0.760755,"eighty":-0.458405,"marketCap":66304838},{"date":"2024-09-20","current":-3.20308,"twenty":-3.135439,"median":-0.764942,"eighty":-0.461887,"marketCap":68481847},{"date":"2024-09-27","current":-3.643975,"twenty":-3.178787,"median":-0.768625,"eighty":-0.462897,"marketCap":77908185},{"date":"2024-10-04","current":-3.786116,"twenty":-3.214164,"median":-0.768787,"eighty":-0.463358,"marketCap":80947156},{"date":"2024-10-11","current":-3.256318,"twenty":-3.2512,"median":-0.769748,"eighty":-0.463499,"marketCap":69620080},{"date":"2024-10-18","current":-3.20463,"twenty":-3.255304,"median":-0.777696,"eighty":-0.46412,"marketCap":68514999},{"date":"2024-10-25","current":-3.152943,"twenty":-3.2512,"median":-0.778868,"eighty":-0.46532,"marketCap":67409919},{"date":"2024-10-31","current":-3.023724,"twenty":-3.252492,"median":-0.779597,"eighty":-0.466029,"marketCap":64647217},{"date":"2024-11-08","current":-2.920349,"twenty":-3.246435,"median":-0.78225,"eighty":-0.467418,"marketCap":62437056},{"date":"2024-11-15","current":-2.558536,"twenty":-3.240854,"median":-0.784347,"eighty":-0.469438,"marketCap":54701491},{"date":"2024-11-22","current":-2.558794,"twenty":-3.232318,"median":-0.791102,"eighty":-0.471718,"marketCap":54707017},{"date":"2024-11-29","current":-2.739442,"twenty":-3.230474,"median":-0.795022,"eighty":-0.47267,"marketCap":58569273},{"date":"2024-12-06","current":-2.584379,"twenty":-3.230474,"median":-0.797467,"eighty":-0.473741,"marketCap":55254032},{"date":"2024-12-13","current":-2.972036,"twenty":-3.221554,"median":-0.799781,"eighty":-0.47387,"marketCap":63542136},{"date":"2024-12-20","current":-2.564997,"twenty":-3.20463,"median":-0.803647,"eighty":-0.474921,"marketCap":54839626},{"date":"2024-12-27","current":-2.506848,"twenty":-3.20463,"median":-0.806207,"eighty":-0.475039,"marketCap":53596411},{"date":"2025-01-03","current":-3.127099,"twenty":-3.2114,"median":-0.808052,"eighty":-0.475596,"marketCap":66857378},{"date":"2025-01-10","current":-2.881583,"twenty":-3.20463,"median":-0.808945,"eighty":-0.47631,"marketCap":61608245},{"date":"2025-01-17","current":-2.698092,"twenty":-3.20463,"median":-0.815352,"eighty":-0.478446,"marketCap":57685209},{"date":"2025-01-24","current":-2.765286,"twenty":-3.20432,"median":-0.816837,"eighty":-0.481062,"marketCap":59121814},{"date":"2025-01-31","current":-2.506848,"twenty":-3.200607,"median":-0.819848,"eighty":-0.481972,"marketCap":53596411},{"date":"2025-02-07","current":-2.713598,"twenty":-3.188329,"median":-0.826287,"eighty":-0.482087,"marketCap":58016733},{"date":"2025-02-14","current":-2.506848,"twenty":-3.178787,"median":-0.830851,"eighty":-0.482431,"marketCap":53596411},{"date":"2025-02-21","current":-2.222566,"twenty":-3.178787,"median":-0.833977,"eighty":-0.482982,"marketCap":47518467},{"date":"2025-02-28","current":-2.323357,"twenty":-3.178787,"median":-0.836434,"eighty":-0.483597,"marketCap":49673374},{"date":"2025-03-07","current":-2.145035,"twenty":-3.178787,"median":-0.841825,"eighty":-0.483604,"marketCap":45860846},{"date":"2025-03-14","current":-2.196464,"twenty":-3.17351,"median":-0.847958,"eighty":-0.485805,"marketCap":46960401},{"date":"2025-03-21","current":-2.132888,"twenty":-3.158228,"median":-0.854887,"eighty":-0.486637,"marketCap":45601152},{"date":"2025-03-28","current":-1.964128,"twenty":-3.152943,"median":-0.866854,"eighty":-0.487368,"marketCap":41993064},{"date":"2025-04-04","current":-2.085992,"twenty":-3.152943,"median":-0.871306,"eighty":-0.488722,"marketCap":32599878},{"date":"2025-04-11","current":-2.262418,"twenty":-3.152943,"median":-0.875775,"eighty":-0.489198,"marketCap":35357074},{"date":"2025-04-17","current":-2.939585,"twenty":-3.152943,"median":-0.881739,"eighty":-0.490836,"marketCap":45939842},{"date":"2025-04-25","current":-2.739481,"twenty":-3.132268,"median":-0.886194,"eighty":-0.49207,"marketCap":42812612},{"date":"2025-05-02","current":-2.904169,"twenty":-3.127099,"median":-0.891223,"eighty":-0.492327,"marketCap":45386350},{"date":"2025-05-09","current":-2.798273,"twenty":-3.106424,"median":-0.899784,"eighty":-0.492888,"marketCap":43731409},{"date":"2025-05-16","current":-2.338518,"twenty":-3.101255,"median":-0.908751,"eighty":-0.493355,"marketCap":40238874},{"date":"2025-05-23","current":-2.650534,"twenty":-3.101255,"median":-0.914348,"eighty":-0.493529,"marketCap":45607747},{"date":"2025-05-30","current":-2.509001,"twenty":-3.092719,"median":-0.916163,"eighty":-0.493996,"marketCap":43172382},{"date":"2025-06-06","current":-2.518927,"twenty":-3.072615,"median":-0.918616,"eighty":-0.494949,"marketCap":43343179},{"date":"2025-06-13","current":-2.744633,"twenty":-3.062696,"median":-0.921672,"eighty":-0.495485,"marketCap":47226897},{"date":"2025-06-20","current":-3.229303,"twenty":-3.095564,"median":-0.926208,"eighty":-0.496241,"marketCap":55566612},{"date":"2025-06-27","current":-3.133725,"twenty":-3.101255,"median":-0.92807,"eighty":-0.497308,"marketCap":53922004},{"date":"2025-07-03","current":-3.775646,"twenty":-3.1324,"median":-0.930363,"eighty":-0.497381,"marketCap":64967542},{"date":"2025-07-11","current":-3.713327,"twenty":-3.152943,"median":-0.93415,"eighty":-0.497487,"marketCap":63895214},{"date":"2025-07-18","current":-6.005902,"twenty":-3.164335,"median":-0.936471,"eighty":-0.497685,"marketCap":103343564},{"date":"2025-07-25","current":-7.588103,"twenty":-3.178787,"median":-0.942975,"eighty":-0.498434,"marketCap":130568481},{"date":"2025-08-01","current":-6.522539,"twenty":-3.20432,"median":-0.946493,"eighty":-0.498956,"marketCap":112233333},{"date":"2025-08-08","current":-6.683988,"twenty":-3.227495,"median":-0.950054,"eighty":-0.499577,"marketCap":115011385},{"date":"2025-08-15","current":-2.66504,"twenty":-3.229238,"median":-0.954196,"eighty":-0.501376,"marketCap":119801562},{"date":"2025-08-22","current":-2.144428,"twenty":-3.227495,"median":-0.96009,"eighty":-0.50282,"marketCap":96398466},{"date":"2025-08-29","current":-2.181614,"twenty":-3.218169,"median":-0.964367,"eighty":-0.504694,"marketCap":98070116},{"date":"2025-09-05","current":-2.206406,"twenty":-3.20463,"median":-0.967699,"eighty":-0.50475,"marketCap":99184549},{"date":"2025-09-12","current":-2.020472,"twenty":-3.20463,"median":-0.970171,"eighty":-0.505978,"marketCap":90826300},{"date":"2025-09-19","current":-1.995681,"twenty":-3.20463,"median":-0.977113,"eighty":-0.50622,"marketCap":89711867},{"date":"2025-09-26","current":-2.094846,"twenty":-3.20308,"median":-0.986053,"eighty":-0.507063,"marketCap":94169600},{"date":"2025-10-03","current":-1.72298,"twenty":-3.190715,"median":-0.990943,"eighty":-0.507809,"marketCap":77453103},{"date":"2025-10-10","current":-2.454316,"twenty":-3.178787,"median":-1.003032,"eighty":-0.508231,"marketCap":110328880},{"date":"2025-10-17","current":-2.268383,"twenty":-3.178787,"median":-1.011955,"eighty":-0.508263,"marketCap":101970632},{"date":"2025-10-24","current":-2.008077,"twenty":-3.178787,"median":-1.013828,"eighty":-0.509531,"marketCap":90269084},{"date":"2025-10-31","current":-1.921308,"twenty":-3.178787,"median":-1.02715,"eighty":-0.510244,"marketCap":86368568},{"date":"2025-11-07","current":-2.057659,"twenty":-3.17351,"median":-1.03568,"eighty":-0.514069,"marketCap":92497950},{"date":"2025-11-14","current":-2.08245,"twenty":-3.1644,"median":-1.048462,"eighty":-0.517571,"marketCap":93612383},{"date":"2025-11-21","current":-3.573595,"twenty":-3.17351,"median":-1.052387,"eighty":-0.51804,"marketCap":176096065},{"date":"2025-11-28","current":-3.187874,"twenty":-3.178787,"median":-1.053972,"eighty":-0.520847,"marketCap":157088871},{"date":"2025-12-05","current":-2.881566,"twenty":-3.178787,"median":-1.055984,"eighty":-0.522418,"marketCap":141994923},{"date":"2025-12-12","current":-2.756774,"twenty":-3.178787,"median":-1.074193,"eighty":-0.524066,"marketCap":135845536},{"date":"2025-12-19","current":-2.609292,"twenty":-3.174565,"median":-1.092713,"eighty":-0.525041,"marketCap":128578079},{"date":"2025-12-26","current":-3.097116,"twenty":-3.168044,"median":-1.096711,"eighty":-0.525896,"marketCap":152616590},{"date":"2026-01-02","current":-3.199219,"twenty":-3.169866,"median":-1.101974,"eighty":-0.526723,"marketCap":157647906},{"date":"2026-01-09","current":-2.529879,"twenty":-3.16427,"median":-1.146476,"eighty":-0.527286,"marketCap":124664833},{"date":"2026-01-16","current":-2.518534,"twenty":-3.161736,"median":-1.157535,"eighty":-0.527599,"marketCap":124105798},{"date":"2026-01-23","current":-3.017703,"twenty":-3.15735,"median":-1.166795,"eighty":-0.528149,"marketCap":148703344},{"date":"2026-01-30","current":-2.892911,"twenty":-3.153661,"median":-1.171596,"eighty":-0.52918,"marketCap":142553958},{"date":"2026-02-06","current":-2.609292,"twenty":-3.152943,"median":-1.176056,"eighty":-0.531342,"marketCap":128578079},{"date":"2026-02-13","current":-2.802153,"twenty":-3.152943,"median":-1.182643,"eighty":-0.53184,"marketCap":138081677},{"date":"2026-02-20","current":-3.289977,"twenty":-3.15384,"median":-1.187631,"eighty":-0.53255,"marketCap":162120187},{"date":"2026-02-27","current":-2.858876,"twenty":-3.152943,"median":-1.194576,"eighty":-0.532998,"marketCap":140876852},{"date":"2026-03-06","current":-2.790808,"twenty":-3.152943,"median":-1.222873,"eighty":-0.533145,"marketCap":137522641},{"date":"2026-03-13","current":-3.176529,"twenty":-3.15384,"median":-1.233649,"eighty":-0.533541,"marketCap":156529836},{"date":"2026-03-20","current":-3.255943,"twenty":-3.152943,"median":-1.240878,"eighty":-0.533659,"marketCap":160443082},{"date":"2026-03-27","current":-4.186212,"twenty":-3.152943,"median":-1.240878,"eighty":-0.533659,"marketCap":206283962},{"date":"2026-04-02","current":-2.740763,"twenty":-3.145951,"median":-1.240878,"eighty":-0.533659,"marketCap":152057555},{"date":"2026-04-10","current":-2.832177,"twenty":-3.116761,"median":-1.240878,"eighty":-0.533659,"marketCap":157129163},{"date":"2026-04-17","current":-3.046118,"twenty":-3.097116,"median":-1.240878,"eighty":-0.533659,"marketCap":168998633},{"date":"2026-04-24","current":-2.567297,"twenty":-3.081445,"median":-1.240878,"eighty":-0.533659,"marketCap":142433630},{"date":"2026-05-01","current":-2.516358,"twenty":-3.063052,"median":-1.240878,"eighty":-0.533659,"marketCap":139607566},{"date":"2026-05-08","current":-2.373731,"twenty":-3.049568,"median":-1.240878,"eighty":-0.533659,"marketCap":131694587},{"date":"2026-05-15","current":-2.169656,"twenty":-3.038894,"median":-1.240878,"eighty":-0.533659,"marketCap":140172779},{"date":"2026-05-22","current":-2.064672,"twenty":-3.013165,"median":-1.240878,"eighty":-0.533659,"marketCap":133390225},{"date":"2026-05-29","current":-2.08217,"twenty":-3.006358,"median":-1.237264,"eighty":-0.5336,"marketCap":134520651},{"date":"2026-06-05","current":-2.241539,"twenty":-2.972209,"median":-1.240878,"eighty":-0.533659,"marketCap":144816861},{"date":"2026-06-12","current":-2.046622,"twenty":-2.949634,"median":-1.240878,"eighty":-0.533659,"marketCap":132224091},{"date":"2026-06-18","current":-2.027131,"twenty":-2.941974,"median":-1.240878,"eighty":-0.533659,"marketCap":130964814},{"date":"2026-06-26","current":-2.017385,"twenty":-2.921855,"median":-1.237264,"eighty":-0.5336,"marketCap":130335175},{"date":"2026-07-02","current":-2.329251,"twenty":-2.90974,"median":-1.237264,"eighty":-0.5336,"marketCap":150483608},{"date":"2026-07-10","current":-2.592388,"twenty":-2.894505,"median":-1.237264,"eighty":-0.5336,"marketCap":167483848},{"date":"2026-07-17","current":-2.275649,"twenty":-2.88158,"median":-1.237264,"eighty":-0.5336,"marketCap":147020596},{"date":"2026-07-24","current":-2.144081,"twenty":-2.872092,"median":-1.237264,"eighty":-0.5336,"marketCap":138520476},{"date":"2026-07-31","current":-2.036877,"twenty":-2.86274,"median":-1.233649,"eighty":-0.533541,"marketCap":131594452},{"date":"2026-08-07","current":-2.134335,"twenty":-2.836187,"median":-1.233649,"eighty":-0.533541,"marketCap":137890838},{"date":"2026-08-14","current":-2.318487,"twenty":-2.824842,"median":-1.233649,"eighty":-0.533541,"marketCap":159954744},{"date":"2026-08-21","current":-2.081162,"twenty":-2.805677,"median":-1.233649,"eighty":-0.533541,"marketCap":143581424},{"date":"2026-08-28","current":-2.081162,"twenty":-2.798273,"median":-1.233649,"eighty":-0.533541,"marketCap":143581424},{"date":"2026-09-04","current":-1.761685,"twenty":-2.790808,"median":-1.233649,"eighty":-0.533541,"marketCap":121540416},{"date":"2026-09-11","current":-1.880348,"twenty":-2.765286,"median":-1.233649,"eighty":-0.533541,"marketCap":129727076},{"date":"2026-09-14","current":-1.862092,"twenty":-2.756774,"median":-1.233649,"eighty":-0.533541,"marketCap":128467590}],"updateTime":1789474655719},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNTB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667406456","title":"Connect Biopharma股價下跌，因其哮喘藥物在早期研究中未達到主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667406456","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667406456?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:24","pubTimestamp":1789478676,"startTime":"0","endTime":"0","summary":"BUZZ-Connect Biopharma股价下跌，因其哮喘药物在早期研究中未达到主要目标9月15日-** 生物技术公司Connect Biopharma（CNTB.O）的股价在盘前交易中下跌28.7%，至1.23美元** 该公司表示，其试验性哮喘药物rademikibart在针对严重哮喘急性发作患者的早期研究中未能达到主要目标，尽管与安慰剂相比，该药物将治疗失败率降低了66%** 公司表示，由","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4S4570Y9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153083148","title":"康乃德生物醫藥：Rademikibart在哮喘患者中展現良好耐受性與低不良事件發生率","url":"https://stock-news.laohu8.com/highlight/detail?id=1153083148","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153083148?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:08","pubTimestamp":1789470534,"startTime":"0","endTime":"0","summary":"在哮喘治疗领域，康乃德生物医药传来令人振奋的消息——其研发的药物Rademikibart展现出卓越的安全性特征。这一候选药物在患者群体中表现出良好的耐受性，同时不良反应的发生率维持在较低水平，为饱受哮喘困扰的患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183435314","title":"康乃德生物醫藥：Rademikibart在第7天展現統計學顯著肺功能改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1183435314","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183435314?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:08","pubTimestamp":1789470533,"startTime":"0","endTime":"0","summary":"康乃德生物医药（Connect Biopharma）近日披露，其候选药物Rademikibart在临床试验中展现出令人瞩目的积极信号。数据显示，与安慰剂对照组相比，接受该药物治疗的患者在用药后仅第7天便实现了肺功能的显著提升——这一差异在统计学上具有明确意义。此结果为该药物在呼吸系统疾病治疗领域的潜力增添了有力佐证，同时也为后续研发进程注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195209241","title":"康乃德生物醫藥公布Rademikibart全球II期研究積極初步頂線數據：作為成人與青少年哮喘合併2型炎症患者急性加重期的附加治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1195209241","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195209241?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:01","pubTimestamp":1789470075,"startTime":"0","endTime":"0","summary":"康乃德生物医药今日宣布，其评估Rademikibart作为附加治疗药物、用于成人和青少年哮喘合并2型炎症患者急性加重期的全球II期研究，已取得令人振奋的初步顶线数据。这项备受瞩目的临床试验，旨在探究Rademikibart在缓解急性哮喘发作方面的潜力与安全性。Rademikibart若能成功研发上市，有望填补当前治疗策略中的重要空白，为患者提供更为精准和有效的干预手段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192576644","title":"奧本海默首予康乃德生物醫藥「跑贏大盤」評級，目標價8美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192576644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192576644?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 20:27","pubTimestamp":1783600039,"startTime":"0","endTime":"0","summary":"投资机构奥本海默近日发布研报，首次将康乃德生物医药纳入研究覆盖范围，并给予其“跑赢大盘”的积极评级。该机构为这家生物技术公司设定的目标股价为每股8美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126934188","title":"Piper Sandler首予康乃德生物醫藥「增持」評級，目標價7美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126934188","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126934188?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 15:40","pubTimestamp":1782459617,"startTime":"0","endTime":"0","summary":"投资银行Piper Sandler近日发布研究报告，首次覆盖康乃德生物医药，并给予其股票“增持”评级，同时设定7美元的目标价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131513063","title":"康乃德生物醫藥宣佈完成評估雷迪米基巴治療哮喘急性發作的II期海風研究患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1131513063","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131513063?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 21:01","pubTimestamp":1781701278,"startTime":"0","endTime":"0","summary":"康乃德生物医药（Connect Biopharma Holdings Ltd.）已宣布其II期“海风”（Seabreeze）研究完成患者入组。该研究旨在评估其候选药物雷迪米基巴（rademikibart）用于治疗哮喘急性发作的疗效与安全性。这项关键性试验的推进，标志着公司在探索呼吸系统疾病创新疗法方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198980770","title":"康乃德生物醫藥控股有限公司 - 計劃轉售至多610萬股普通股 - 美國證券交易委員會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1198980770","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198980770?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 20:34","pubTimestamp":1778848459,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）提交的文件，康乃德生物医药控股有限公司（Connect Biopharma Holdings Ltd.）计划进行一项普通股转售。文件显示，此次拟议的转售涉及高达610万股公司普通股。\n这一行动通常意味着现有股东，例如早期投资者或公司内部人士，可能计划在公开市场上出售其持有的部分股份。此类转售备案是资本市场中的常规操作，旨在提前向市场披露潜在的股票供应增加，确保信息的透明性。投资者通常会关注此类动向，以评估其对公司股价可能产生的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114135897","title":"康乃德生物醫藥：兩項Seabreeze Stat研究頂線結果預計年中公布，目前進展順利","url":"https://stock-news.laohu8.com/highlight/detail?id=1114135897","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114135897?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 21:13","pubTimestamp":1778591604,"startTime":"0","endTime":"0","summary":"康乃德生物医药目前进展顺利，预计仍将按计划于今年年中公布其两项Seabreeze Stat研究的关键顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108235284","title":"康乃德生物醫藥：數據監測委員會報告Seabreeze Stat研究無安全隱患或治療相關嚴重不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1108235284","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108235284?lang=zh_tw&edition=fundamental","pubTime":"2026-04-23 21:10","pubTimestamp":1776949846,"startTime":"0","endTime":"0","summary":"康乃德生物医药控股有限公司宣布，其独立数据监测委员会针对Seabreeze Stat临床研究项目完成最新安全评估。评估结果显示，试验中未发现任何值得关注的安全性问题，也未出现与治疗方案相关的严重不良事件报告。这一积极进展为候选药物的后续研发进程提供了重要的安全性数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174518832","title":"康乃德生物醫藥：預設定中期分析後，Seabreeze二期研究將按計劃繼續推進患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1174518832","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174518832?lang=zh_tw&edition=fundamental","pubTime":"2026-04-23 21:09","pubTimestamp":1776949756,"startTime":"0","endTime":"0","summary":"康乃德生物医药控股有限公司宣布，其Seabreeze二期临床试验在完成预设的中期分析后，决定按原定方案持续推进患者招募工作。此项分析旨在评估研究的有效性与安全性参数，结果表明当前试验进展符合预期轨迹，支持继续开展后续研究阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190885068","title":"康乃德生物醫藥公布靜脈注射雷德米基巴治療哮喘或慢阻肺患者一期研究積極頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1190885068","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190885068?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 21:39","pubTimestamp":1774877955,"startTime":"0","endTime":"0","summary":"康乃德生物医药控股有限公司宣布，其静脉注射雷德米基巴在哮喘或慢性阻塞性肺病患者中开展的一期研究获得积极顶线结果。\n研究数据显示，通过静脉推注给予300毫克雷德米基巴后，哮喘和慢阻肺患者的第一秒用力呼气容积迅速改善，增幅达到或超过200毫升。该药物展现出良好的耐受性，研究中未出现严重或重度不良事件。\n目前，公司正在推进第二阶段SEABREEZE STAT研究的患者招募工作，该项研究的顶线数据预计将于2026年中期公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312839","title":"BUZZ-濕疹藥物在中國研究中顯示出持久療效，Connect 生物製藥公司業績上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312839","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312839?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:42","pubTimestamp":1774870956,"startTime":"0","endTime":"0","summary":"** 称雷迪米克巴特尚未在任何地方获得批准，正在寻求中国以外的合作伙伴** 2025 年 CNTB 增长约两倍(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4T40I10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167678957","title":"康乃德生物醫藥宣佈完成2020萬美元私募融資 資金儲備將支撐運營至2027年下半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1167678957","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167678957?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:05","pubTimestamp":1774868718,"startTime":"0","endTime":"0","summary":"临床阶段生物制药企业康乃德生物医药近日与特定机构投资者达成证券购买协议，通过非公开配售发行613万股普通股，每股定价3.25美元。此次融资由现有最大投资方帕纳西亚创投领投，并吸引多家美国医疗健康领域新老投资者参与。本次私募预计募集总额约2020万美元，交易预计于2026年3月31日左右完成。结合现有现金及短期投资，本轮融资将使公司运营资金储备延续至2027年下半年。公司承诺在交易完成45天内向美国证交会提交转售股份登记声明。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198277618","title":"康乃德生物醫藥Rademikibart在長達52周的特應性皮炎3期研究中展現快速且持久的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1198277618","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198277618?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:05","pubTimestamp":1774868713,"startTime":"0","endTime":"0","summary":"康乃德生物医药宣布，其核心候选药物Rademikibart在针对中重度特应性皮炎患者开展的3期临床研究中，展现出快速起效且持久的治疗效果，疗效数据持续至第52周。\n研究结果显示，Rademikibart能够显著改善患者的皮损严重程度和瘙痒症状。其疗效在治疗初期便迅速显现，并在此后长达一年的观察期内得以稳定维持，凸显了该药物在长期疾病管理中的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174454518","title":"康乃德生物醫藥公布靜脈注射Rademikibart針對哮喘或慢阻肺患者一期研究的積極頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1174454518","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174454518?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:02","pubTimestamp":1774868539,"startTime":"0","endTime":"0","summary":"康乃德生物医药宣布，其静脉注射（IV）Rademikibart在哮喘或慢性阻塞性肺疾病（COPD）患者中进行的1期研究获得了积极的顶线数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139187190","title":"康乃德生物醫藥Rademikibart 300毫克靜脈推注在哮喘與慢阻肺治療中實現FEV1快速改善≥200毫升","url":"https://stock-news.laohu8.com/highlight/detail?id=1139187190","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139187190?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:01","pubTimestamp":1774868484,"startTime":"0","endTime":"0","summary":"康乃德生物医药宣布，其研发的Rademikibart 300毫克静脉推注剂型在针对哮喘及慢性阻塞性肺病的临床研究中取得突破性进展。数据显示，该治疗方案能够促使患者第一秒用力呼气容积实现快速且显著的提升，改善幅度达到或超过200毫升。这一结果凸显了Rademikibart在呼吸系统疾病治疗领域的潜在价值。康乃德生物医药将继续推进相关临床研究，深入探索Rademikibart的疗效与安全性，致力于为全球呼吸疾病患者带来更优的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186382748","title":"康乃德生物醫藥Rademikibart耐受性良好，未出現嚴重或重度不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1186382748","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186382748?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:01","pubTimestamp":1774868477,"startTime":"0","endTime":"0","summary":"康乃德生物医药控股有限公司公布的最新数据显示，其核心候选药物Rademikibart在临床试验中表现出良好的耐受性。研究期间未报告任何严重或重度不良事件，这一结果进一步支持了该药物的安全性特征。Rademikibart作为一种新型治疗性抗体，目前正针对多种免疫介导性疾病开展临床研究。此次积极的安全性数据为其后续开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120708929","title":"康乃德生物醫藥Seabreeze Stat二期研究持續招募受試者，頂線數據預計2026年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1120708929","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120708929?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:01","pubTimestamp":1774868473,"startTime":"0","endTime":"0","summary":"康乃德生物医药控股有限公司宣布，其针对Seabreeze Stat的二期临床研究目前正在进行患者招募工作。该项研究的关键顶线数据结果预计将于2026年中期获得。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}